Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

ADDvance Pharma in Scandinavia AB

Closing information (x1000 NOK)

Closing information 2025/08 2024/08 2023/08
Turnover 21,687 Less Arrow 21,480 Less Arrow 19,686
Financial expenses 2 More Arrow 16 Less Arrow 0
Earnings before taxes 3,869 More Arrow 4,687 Less Arrow 4,076
EBITDA 3,511 More Arrow 4,541 Less Arrow 3,915
Total assets 14,369 Less Arrow 12,711 Less Arrow 11,206
Current assets 13,096 Less Arrow 8,945 More Arrow 9,012
Current liabilities 3,832 Less Arrow 2,460 More Arrow 5,106
Equity capital 9,810 Less Arrow 9,596 Less Arrow 5,604
- share capital 106 Less Arrow 103 Less Arrow 98
Employees (average) 2 Equal arrow 2 Equal arrow 2

Financial ratios

Fiscal year 2025/08 2024/08 2023/08
Solvency 68.3% More Arrow 75.5% Less Arrow 50.0%
Turnover per employee 10,844 Less Arrow 10,740 Less Arrow 9,843
Profit as a percentage of turnover 17.8% More Arrow 21.8% Less Arrow 20.7%
Return on assets (ROA) 26.9% More Arrow 37.0% Less Arrow 36.4%
Current ratio 341.8% More Arrow 363.6% Less Arrow 176.5%
Return on equity (ROE) 39.4% More Arrow 48.8% More Arrow 72.7%
Change turnover -499 More Arrow 714 More Arrow 6,434
Change turnover % -2% More Arrow 3% More Arrow 49%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2025/08 2024/08 2023/08
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.